Studies have shown that the JAK2–STAT3 pathway is overactivated in other types of AKI [32,37–39], and DMF has been shown to play a therapeutic role in several diseases by inhibiting the STAT3 pathway [40–42]. The gene discussed is JAK2; the disease is acute kidney injury.